UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study

Thrombosis and haemostasis, 1993-09, Vol.70 (3), p.380-385

1993

Volltextzugriff (PDF)

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors

Atherosclerosis, 1991-12, Vol.91 (3), p.191-205

1991

Volltextzugriff (PDF)

Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study

Thrombosis and haemostasis, 1993-11, Vol.70 (5), p.762-767

1993

Volltextzugriff (PDF)

343PPhase I dose escalation study of a selective androgen receptor modulator RAD140 in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer (BC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency

Annals of internal medicine, 1986-12, Vol.105 (6), p.873

1986

Volltextzugriff (PDF)

Plasma Vitronectin Polymorphism in Normal Subjects and Patients With Disseminated Intravascular Coagulation

Blood, 1988-07, Vol.72 (1), p.185-190

1988

Volltextzugriff (PDF)

Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 1991-03, Vol.7 (3), p.235-240

1991

Volltextzugriff (PDF)

Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer

Anti-cancer drugs, 2012-03, Vol.23 (3), p.335-341

2012

Volltextzugriff (PDF)

Prothrombotic abnormalities in inflammatory bowel disease

Digestive diseases and sciences, 1989-07, Vol.34 (7), p.1089-1093

1989

Volltextzugriff (PDF)

Porphyria cutanea tarda in association with human immunodeficiency virus infection in a hemophiliac

Journal of the American Academy of Dermatology, 1992-05, Vol.26 (5), p.857-859

1992

Volltextzugriff (PDF)

Disseminated intravascular coagulation and hemorrhage in hemophilia B following elective surgery

American journal of hematology, 1990-11, Vol.35 (3), p.203-207

1990

Volltextzugriff (PDF)

Low protein s in essential thrombocythemia with thrombosis

American journal of hematology, 1989-10, Vol.32 (2), p.88-93

1989

Volltextzugriff (PDF)

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

Transfusion (Philadelphia, Pa.), 2005-12, Vol.45 (12), p.1864-1875

2005

Volltextzugriff (PDF)

Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 1991-06, Vol.7 (6), p.475-479

1991

Volltextzugriff (PDF)

Familial type II protein C deficiency associated with warfarin‐induced skin necrosis and bilateral adrenal hemorrhage

American journal of hematology, 1988-12, Vol.29 (4), p.226-229

1988

Volltextzugriff (PDF)

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set

Transfusion (Philadelphia, Pa.), 2005-09, Vol.45 (9), p.1443-1452

2005

Volltextzugriff (PDF)

Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia

Transfusion (Philadelphia, PA), 2006-05, Vol.46 (5), p.731-740

2006

Volltextzugriff (PDF)

Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment

Transfusion (Philadelphia, Pa.), 2005-10, Vol.45 (10), p.1610-1620

2005

Volltextzugriff (PDF)

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

Transfusion (Philadelphia, Pa.), 2005-11, Vol.45 (11), p.1739-1749

2005

Volltextzugriff (PDF)

Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light

Transfusion (Philadelphia, Pa.), 2006-01, Vol.46 (1), p.24-33

2006

Volltextzugriff (PDF)

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma

Blood, 2008-11, Vol.112 (11), p.1563-1563

2008

Volltextzugriff (PDF)

Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study

Ethnicity & disease, 1992, Vol.2 (1), p.35

1992

Volltextzugriff (PDF)

Clinical significance of hematologic parameters in non‐Hodgkin's lymphoma at diagnosis

Cancer, 1991-03, Vol.67 (5), p.1389-1395

1991

Volltextzugriff (PDF)

Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study

Transfusion (Philadelphia, Pa.), 2006-03, Vol.46 (3), p.424-433

2006

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Englisch
(113)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(69)
Humans
(65)
Male
(44)
Female
(43)
Biological And Medical Sciences
(35)
Middle Aged
(33)
Medical Sciences
(30)
Adult
(29)
Hematology
(24)
Fundamental And Applied Biological Sciences. Psychology
(13)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(12)
Animals
(12)
Adolescent
(11)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(11)
Oncology
(10)
Aged
(9)
Orthopedics
(9)
Risk Factors
(9)
Treatment Outcome
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study

Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors

Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study

343PPhase I dose escalation study of a selective androgen receptor modulator RAD140 in estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer (BC)

Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency

Plasma Vitronectin Polymorphism in Normal Subjects and Patients With Disseminated Intravascular Coagulation

Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation

Phase I dose-escalation and pharmacokinetic study of ispinesib, a kinesin spindle protein inhibitor, administered on days 1 and 15 of a 28-day schedule in patients with no prior treatment for advanced breast cancer

Prothrombotic abnormalities in inflammatory bowel disease

Porphyria cutanea tarda in association with human immunodeficiency virus infection in a hemophiliac

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

Disseminated intravascular coagulation and hemorrhage in hemophilia B following elective surgery

Low protein s in essential thrombocythemia with thrombosis

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation

Familial type II protein C deficiency associated with warfarin‐induced skin necrosis and bilateral adrenal hemorrhage

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set

Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia

Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma

Distributions of hemostatic variables in blacks and whites: population reference values from the Atherosclerosis Risk in Communities (ARIC) Study

Clinical significance of hematologic parameters in non‐Hodgkin's lymphoma at diagnosis

Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study

Suchergebnisse filtern